Stockscreener 앱 받기
0.00
100.00%
-23.80
전일 마감가:
$23.80
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$27.53
Tema Neuroscience And Mental Health Etf Stock (MNTL) Company Profile
명칭
Tema Neuroscience And Mental Health Etf
전화
-
주소
-
MNTL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MNTL
Tema Neuroscience And Mental Health Etf
|
0.00 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
321.81 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
652.23 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
655.51 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
253.60 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
580.70 | 124.43B | 0 | 0 | 0 | 0.00 |
Tema Neuroscience And Mental Health Etf 주식(MNTL)의 최신 뉴스
Tema Surpasses $1bn AUM Two Years After Launch, Strengthens Team With Key Growth Hires - Business Wire
Vertex Pharmaceuticals Plunges 19.28%—What Crisis Unfolds in Biotech's Pain Frontier? - AInvest
Vertex Pharmaceuticals Plunges 19.23%—What Storm is Brewing in Biotech? - AInvest
Alnylam Pharmaceuticals Surges 3.79% Intraday – What’s Fueling This Sudden Rally? - AInvest
Weekly ETF Industry Recap: U.S., Europe, and Canada Highlights – June 30-July 4, 2025 - Trackinsight
Tema Announces Liquidation of Two ETFs - Business Wire
The Unseen Storm: How Section 899 Could Trigger a Foreign Capital Exodus from U.S. Equities - AInvest
Tema Launches the S&P 500 Historical Weight ETF Strategy (DSPY), First S&P 500 Concentration Innovation Since 2003 - Business Wire
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
Hone Your Biotech Allocation With Neuroscience ETF MNTL - ETF Trends
Tema Launches World’s First Electrification ETF ($VOLT) - Business Wire
Where to Invest in Health Trends - Bloomberg.com
Tema ETFs CIO on the Power of Biotech as a Source of Return Yuri Khodjamirian on Opportunities to Invest in Biotech - CMC Markets
Pursuing A Better Way To Invest In Life Sciences | Opto Partners - CMC Markets
Biogen cost cuts drive profit beat, as Alzheimer's drug off to slow start - Reuters
Benzinga's 2024 Virtual Healthcare Summit: What's Next In Health? - Benzinga
Luma, Yieldstreet Expand Alts Partnership - FA Mag
Tema ETFs: A Better Way to Invest in Life Sciences - StreetInsider
Tema Launches Third Medical-Themed ETF - FA Mag
Active ETF Stat Pack - NYSE
This Week in ETFs: Closures Outnumber New ETFs - ETF Trends
Biotechnology ETF List - ETFdb.com
Tema Neuroscience And Mental Health Etf (MNTL) 재무 분석
Tema Neuroscience And Mental Health Etf (MNTL)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.78%
0.02%
자본화:
|
볼륨(24시간):